Rheonix, Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. As scientific knowledge evolves, so does the need for new diagnostic technology to simplify processes and enhance innovation. Rheonix, through experienced leadership and creative vision, has developed the Encompass platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD® cartridge. With both the Rheonix CARD and Encompass family of products, Rheonix is well-positioned to penetrate key molecular diagnostic market sectors, from reference labs through point-of-care and everywhere in-between.
Location: United States, New York, Ithaca
Employees: 51-200
Total raised: $27.1M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Cayuga Ven... | cayugavent... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 19.12.2013 | - | $14M | - |
| 06.11.2013 | - | $500K | - |
| 21.04.2010 | Series A | $12.6M | - |
Mentions in press and media 2
| Date | Title | Description |
| 21.04.2010 | Rheonix Completes $12.6M Series A financing | Rheonix, Inc., an Ithaca, NY-based developer of a polymer chip microfluidic technology for the molecular diagnostics industry, completed a $12.6m Series A financing. The funding was provided by a syndicate of regional and international firm... |
| 06.11.2009 | Rheonix Secures $250,000 Equity Funding | Rheonix, Inc., a Ithaca, New York-based spin out of the microfluidic division of Kionix, Inc., secured a $250,000 equity funding from Rand Capital Corporation (Nasdaq:RAND), a business development company that provides capital and manageria... |